These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HUMAN ADENOVIRUS TYPE 31. A NEW SEROTYPE WITH ONCOGENIC PROPERTIES. PEREIRA MS, PERIERA HG, CLARKE SK. Lancet; 1965 Jan 02; 1(7375):21-3. PubMed ID: 14246675 [No Abstract] [Full Text] [Related]
12. QUANTITATIVE STUDIES OF NATURAL AND EXPERIMENTAL ADENOVIRUS INFECTIONS OF HUMAN CELLS. II. PRIMARY CULTURES AND THE POSSIBLE ROLE OF ASYNCHRONOUS VIRAL MULTIPLICATION IN THE MAINTENANCE OF INFECTION. STROHL WA, SCHLESINGER RW. Virology; 1965 Jun 13; 26():208-20. PubMed ID: 14323989 [No Abstract] [Full Text] [Related]
15. ADENOVIRUS-LIKE PARTICLES FROM CANCERS INDUCED BY ADENOVIRUS-12 BUT FREE OF INFECTIOUS VIRUS. SMITH KO, MELNICK JL. Science; 1964 Sep 11; 145(3637):1190-2. PubMed ID: 14173408 [Abstract] [Full Text] [Related]
16. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS. WILCOX WC, GINSBERG HS. Proc Soc Exp Biol Med; 1963 Oct 11; 114():37-42. PubMed ID: 14076907 [No Abstract] [Full Text] [Related]
17. MANIFESTATIONS OF LATENT VIRAL GENETIC MATERIAL IN EXPERIMENTALLY PRODUCED CANCERS AND SEARCH FOR SUCH MANIFESTATIONS IN HUMAN CANCERS. SABIN AB. Isr J Med Sci; 1965 Jan 11; 1():93-103. PubMed ID: 14252808 [No Abstract] [Full Text] [Related]